The Broadening Application of Chemodenervation in X-Linked Dystonia-Parkinsonism (Part II): An Open-Label Experience With Botulinum Toxin-A (Dysport®) Injections for Oromandibular, Lingual, and Truncal-Axial Dystonias

REFERENCES

• Agur, A., & Lee, M. J. (1999). Grant's atlas of anatomy (10th edn). Philadelphia: Lippincott Williams and Wilkins.
   Google Scholar
• Albanese, A., Asmus, F., Bhatia, K. P., Elia, A. E., Elibol, B., Filippini, G., (2010). EFNS guidelines on diagnosis and treatment of primary dystonias. European Journal of Neurology, 18(1), 5–18.
   Web of Science ®Google Scholar
• Barbano, R. (2007). Anatomic principles for botulinum toxin injection. In M. Stacy Mark (ed.), Neurological disease and therapy: Handbook of dystonia (pp. 317–341). New York: Informa Healthcare.
   Google Scholar
• Benecke, R., Moore, P., Dressler, D., & Naumann, M. (2003). Cervical and axial dystonia. In P. Moore & M. Naumann (eds.), Handbook of botulinum toxin treatment (2nd edn). UK: Blackwell Science Ltd, 158–191.
   Google Scholar
• Berardelli, A., Gilio, F., & Curra, A. (2002). Effects of botulinum toxin type A on central nervous system function. In M. F. Brin, J. Jankovic & M. Hallett (eds.), Scientific and therapeutic aspects of botulinum toxin (pp. 171–177). Philadelphia: Lippincott, Williams & Wilkins.
   Google Scholar
• Berkovitz, B. K. B., & Moxham, B. J. (1988). A textbook of head and neck anatomy (pp. 171–189). London: Yearbook Medical Publishers, Inc.
   Google Scholar
• Bhidayasiri, R., Cardoso, F., & Truong, D. (2008). Botulinum toxin in blepharospasm and oromandibular dystonia: Comparing different botulinum toxin preparations. European Journal of Neurology, 13(Suppl. 1), 21–29.
   Google Scholar
• Blitzer, A., Brin, M. F., & Fahn, S. (2009). Botulinum toxin injections for lingual dystonia. Laryngoscope, 101(7), 799.
   Google Scholar
• Bonanni, L., Thomas, A., Varanese, S., Scorrano, V., & Onofrij, M. (2007). Botulinum toxin treatment of lateral axial dystonia in Parkinsonism. Movement Disorders, 22, 2097–2103.
   PubMed Web of Science ®Google Scholar
• Brin, M. F., Danisi, F., & Blitzer, A (2003). Blepharospasm, oromandibular dystonia, Meige's syndrome and hemifacial spasm. In P. Moore, & M. Naumann (eds.), Handbook of botulinum toxin treatment (2nd edn). UK: Blackwell Science Ltd, 119– 141.
   Google Scholar
• Brin, M., Blitzer, A., Herman, S., & Steward, C. (1994). Oromandibular dystonia: Treatment of 96 cases with botulinum A. In J. Jankovic & M. Hallett (eds.), Therapy with botulinum toxin (pp. 429–435). New York: Marcel Dekker.
   Google Scholar
• Charles, P. D., Davis, T. L., Shannon, K. M., Hook, M. A., & Warner, J. S. (1997). Tongue protrusion dystonia: Treatment with botulinum toxin. Southern Medical Journal, 90, 522– 525.
   PubMed Web of Science ®Google Scholar
• Comella, C. L., Shannon, K. M., & Jaglin, J. (1998). Extensor truncal dystonia: Successful treatment with botulinum toxin injections. Movement Disorders, 13, 552–555.
   PubMed Web of Science ®Google Scholar
• Curra, A., Trompetto, C., Abbruzzese, G., & Berardelli, A. (2004). Central effects of botulinum toxin A. Evidence and supposition. Movement Disorders, 19, S60–S64.
   Google Scholar
• Gelb, D. J., Yoshimura, D. M., Olney, R. K., Lowenstein, D. H., & Aminoff, M. J. (1991). Change in the pattern of muscle activity following botulinum toxin injections for torticollis. Annals of Neurology, 29, 370–376.
   PubMed Web of Science ®Google Scholar
• Hawthorne, M., Anwar, K., Ward, A. B., & Barnes, M. P. (2007). Clinical uses of botulinum toxins (pp. 111–121). UK: Cambridge University Press.
   Google Scholar
• Kanovsky, P., Streitova, H., Bares, M., & Hortova, H. (1999). Treatment of facial and orolingomandibular tardive dystonia by botulinum toxin-A: Evidence of long lasting effect. Movement Disorders, 14, 886–888.
   PubMed Web of Science ®Google Scholar
• Kasravi, N., & Jog, M. S. (2009). Botulinum toxin in the treatment of lingual movement disorders. Movement Disorders, 24, 2199– 2202.
   PubMedGoogle Scholar
• Kim, D., Oh, B., & Paik, N. (2006). Central effect of botulinum toxin type A in humans. International Journal of Neuroscience, 116, 667–680.
   PubMed Web of Science ®Google Scholar
• Lee, L. V., Kupke, K. G., Caballar-Gonzaga, F., Hebron-Ortiz, M., & Muller, U. (1991). The phenotype of the X-linked dystonia-parkinsonism syndrome. An assessment of 42 cases in the Philippines. Medicine (Baltimore), 70(3), 179–187.
   PubMed Web of Science ®Google Scholar
• Lee, L. V., Maranon, E., Demaisip, C., Peralta, O., Borres-Icasiano, R., Arancillo, J., (2002). The natural history of sex-linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Parkinsonism & Related Disorders, 9(1), 29–38.
   PubMed Web of Science ®Google Scholar
• Lee, L. V., Munoz, E. L., Tan, K. T., & Reyes, M. T. (2001). Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Molecular Pathology, 54(6), 362–368.
   PubMedGoogle Scholar
• Moore, P., & Naumann, M. (2003). Handbook of botulinum toxin treatment (2nd edn). UK: Blackwell Science Ltd.
   Google Scholar
• Muller, U., Herzfeld, T., & Nolte, D. (2007). The TAF1/DYT3 multiple transcript system in X-linked dystonia-parkinsonism. American Journal of Human Genetics, 81, 415–417.
   PubMed Web of Science ®Google Scholar
• Novak, I., Campbell, L., Boyce, M., & Fung, V. S. C. (2010). Botulinum toxin assessment, intervention and aftercare for cervical dystonia and other causes of hypertonia of the neck: International consensus statement. European Journal of Neurology, 17(Suppl. 2), S94–S108.
   PubMedGoogle Scholar
• Quirk, J. A., Sheean, G. L., Marsden, C. D., & Lees, A. J. (1996). Treatment of nonoccupational limb and trunk dystonia with botulinum toxin. Movement Disorders, 11, 377–383.
   PubMed Web of Science ®Google Scholar
• Reichel, G., & Stenner, A. (2009). Lingual treatment dystonia with botulinum toxin injections. Nervenarzt, 80, 959– 962.
   PubMed Web of Science ®Google Scholar
• Rosales, R. L., Arimura, K., Gamez, G., & Osame, M. (1995). X-linked dystonia-parkinsonism: botulinum toxin therapy and stimulation single-fiber electromyography. Electroencephalography and Clinical Neurophysiology (Section of Electromyography and Motor Control), 97(Suppl.), S234–S235.
   Google Scholar
• Rosales, R. L., Arimura, K., Takenaga, S., & Osame, M. (1996). Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle & Nerve, 19, 488–496.
   PubMed Web of Science ®Google Scholar
• Rosales, R. L., Bigalke, H., & Dressler, D. (2006). Pharmacology of botulinum toxin: Differences between type A preparations. European Journal of Neurology, 13(Suppl. 1), 2–10.
   PubMed Web of Science ®Google Scholar
• Rosales, R. L., & Chua-Yap, A. (2008). Evidence-based systematic review on the efficacy and safety of botulinum toxin therapy in post-stroke spasticity. Journal of Neural Transmission, 115(4), 617–623.
   PubMed Web of Science ®Google Scholar
• Rosales, R. L., Delgado, M., & Malicdan, M. (2004). Botulinum toxin A and muscle afferent block in X-linked dystonia-parkinsonism of panay. Movement Disorders, 19(Suppl. 9), S103–S104.
   Google Scholar
• Rosales, R. L., Delgado, M. S., & Rosales, M. E. (2002). Spasticity, X-linked dystonia, parkinsonism and botulinum toxin A: The local scenario. In L. Battistin, M. Dam & P. Tonin (eds.), Proceedings of the 3rd world congress of neurological rehabilitation. (pp. 121–1260). Italy: Monduzzi Editore.
   Google Scholar
• Rosales, R. L., & Dressler, D. (2010). On Muscle spindles, dystonia and botulinum toxin. European Journal of Neurology, (Suppl. 1), S71–S80.
   Google Scholar
• Shill, H. A., & Hallet, M. (2007). Physiology of primary dystonia. In M. Stacy (ed.), Neurological disease and therapy: Handbook of dystonia. (pp. 57–64). New York: Informa Healthcare.
   Google Scholar
• Susatia, F., Rosales, R. L., Diaz, J. B., & Gumangan, M. C. (2008). Comparison on morphologic changes on nerve terminals, extrafusal and intrafusal muscles following botulinum toxin-A versus botulinum toxin-B injections in experimental rats. Neurorehabilitation & Neural Repair, 22, S203.
   Google Scholar
• Tamiya, G., Makino, S., & Kaji, R. (2007). TAF1 as the most plausible disease Gene for XDP/DYT3. American Journal of Human Genetics, 81, 417–418.
   Web of Science ®Google Scholar
• Tan, E. K., & Jankovic, J. (1999). Botulinum toxin A in patients with oromandibular dystonia: Long-term follow-up. Neurology, 53, 2102–2107.
   PubMed Web of Science ®Google Scholar
• Tintner, R., & Jankovic, J. (2002). Botulinum toxin type A in the management of oromandibular dystonia and bruxism In M. F. Brin, M. Hallett, and J. Jankovic (eds.), Scientific and therapeutic aspects of botulinum toxin (pp. 343–350). Philadelphia: Lippincott, Williams & Wilkins
   Google Scholar
• Trompetto, C., Abbruzzese, G., Suppa, A., & Berardelli, A. (2009). Effects of botulinum toxin on central nervous system function. In J. Jankovic, A. Albanese, M. Z. Atassi, J. O. Dolly, M. Hallett & N. H. Mayer (eds.), Botulinum toxin. Therapeutic clinical practice and science (pp. 85–91). Philiadelphia: Saunders Elsevier.
   Google Scholar
• Truong, D., Dressler, D., & Hallett, M. (2009b). Manual of botulinum toxin therapy. Cambridge: Cambridge University Press.
   Google Scholar
• Truong, D., Stenner, A., & Reichel, G. (2009a). Current clinical applications of botulinum toxin. Current Pharmaceutical Design, 15(31), 3671–3680.
   PubMed Web of Science ®Google Scholar
• Valls-Sole, J., Tolosa, E. S., & Riber, G. (1991). Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. Journal of Neurology, Neurosurgery & Psychiatry, 54, 310–313.
   PubMed Web of Science ®Google Scholar
• Ward, A. B., & Barnes, M. P. (2007). Clinical uses of botulinum toxins. UK: Cambridge University Press.
   Google Scholar
• Witzig, J. W., & Sphal, T. J. (1991). Clinical management of basic maxillofacial orthopedic appliances. In Temporomandibular joint ( Chapter 4, Vol. 3, pp. 188–286). Chicago: Mosby Year Book Publishers.
   Google Scholar
• Young, N., & Blitzer, A. (2009). Treatment of oromandibular dystonia, bruxism and temporo-mandibular disorders with botulinum toxin. In J. Jankovic, A. Albanese, M. Z. Atassi, J. O. Dolly, M. Hallett & N. H. Mayer (eds.), Botulinum toxin. Therapeutic clinical practice and science (pp. 204–219). Philiadelphia: Saunders Elsevier.
   Google Scholar